Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Truly on hold !

<< Previous

Bullboard Posts

Next >>

Post by rico91on Mar 10, 2021 1:35pm

185 Views

Post# 32763923

Truly on hold !

Here we are 4 hours into the trading day and less than 200k shares traded ! That is hardly anything.
There are a number of posters including me that have alot more shares than that!
No one wants to buy and no one wants to sell. How long will this go on before the company tells us when results should be released? Maybe they will just halt trading and release the results without any other warning.
I'll just wait like most everyone else I guess!

Rico

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"